• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噬菌体治疗在 和相关疾病方面的评估。

Evaluation of Phage Therapy in the Context of and Its Associated Diseases.

机构信息

APC Microbiome Ireland, University College Cork, Cork T12 YT20, Ireland.

School of Microbiology, University College Cork, Cork T12 YN60, Ireland.

出版信息

Viruses. 2019 Apr 20;11(4):366. doi: 10.3390/v11040366.

DOI:10.3390/v11040366
PMID:31010053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6521178/
Abstract

Bacteriophages (phages) or bacterial viruses have been proposed as natural antimicrobial agents to fight against antibiotic-resistant bacteria associated with human infections. is a gut commensal, which is occasionally found in the mouth and vaginal tract, and does not usually cause clinical problems. However, it can spread to other areas of the body and cause life-threatening infections, such as septicemia, endocarditis, or meningitis, in immunocompromised hosts. Although phage cocktails are not commercially available within the EU or USA, there is an accumulated evidence from in vitro and in vivo studies that have shown phage efficacy, which supports the idea of applying phage therapy to overcome infections associated with . In this review, we discuss the potency of bacteriophages in controlling , in both in vitro and in vivo scenarios. associated bacteriophages were compared at the genome level and an attempt was made to categorize phages with respect to their suitability for therapeutic application, using orthocluster analysis. In addition, phages have been examined for the presence of antibiotic-resistant genes, to ensure their safe use in clinical conditions. Finally, the domain architecture of phage-encoded endolysins are discussed.

摘要

噬菌体(phages)或细菌病毒被提议作为天然抗菌剂,以对抗与人类感染相关的抗生素耐药菌。是一种肠道共生菌,偶尔存在于口腔和阴道,通常不会引起临床问题。然而,它可以传播到身体的其他部位,并在免疫功能低下的宿主中引起危及生命的感染,如败血症、心内膜炎或脑膜炎。尽管噬菌体鸡尾酒在欧盟或美国没有商业化,但来自体外和体内研究的累积证据表明噬菌体具有疗效,这支持了应用噬菌体疗法来克服与相关的感染的想法。在这篇综述中,我们讨论了噬菌体在控制和体外和体内场景中的效力。在基因组水平上比较了相关的噬菌体,并尝试使用正交聚类分析根据其治疗应用的适用性对噬菌体进行分类。此外,还检查了 噬菌体中是否存在抗生素耐药基因,以确保其在临床条件下的安全使用。最后,讨论了噬菌体编码的内溶素的结构域架构。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d4/6521178/3f4762f3ca62/viruses-11-00366-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d4/6521178/d1f9005fe4d8/viruses-11-00366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d4/6521178/e7e688b98053/viruses-11-00366-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d4/6521178/3f4762f3ca62/viruses-11-00366-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d4/6521178/d1f9005fe4d8/viruses-11-00366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d4/6521178/e7e688b98053/viruses-11-00366-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d4/6521178/3f4762f3ca62/viruses-11-00366-g003.jpg

相似文献

1
Evaluation of Phage Therapy in the Context of and Its Associated Diseases.噬菌体治疗在 和相关疾病方面的评估。
Viruses. 2019 Apr 20;11(4):366. doi: 10.3390/v11040366.
2
Characterization and Anti-Biofilm Activity of Lytic Enterococcus Phage vB_Efs8_KEN04 against Clinical Isolates of Multidrug-Resistant in Kenya.肯尼亚产溶肠球菌噬菌体 vB_Efs8_KEN04 的特性及其抗多药耐药临床分离株的生物膜活性
Viruses. 2024 Aug 9;16(8):1275. doi: 10.3390/v16081275.
3
Molecular Basis for Lytic Bacteriophage Resistance in Enterococci.肠球菌中溶菌性噬菌体抗性的分子基础
mBio. 2016 Aug 30;7(4):e01304-16. doi: 10.1128/mBio.01304-16.
4
Bacteriophage Resistance Alters Antibiotic-Mediated Intestinal Expansion of Enterococci.噬菌体抗性改变了抗生素介导的肠球菌肠道扩张。
Infect Immun. 2019 May 21;87(6). doi: 10.1128/IAI.00085-19. Print 2019 Jun.
5
Phage-Bacteria Interactions in Potential Applications of Bacteriophage vB_EfaS-271 against .噬菌体 vB_EfaS-271 对. 的潜在应用中噬菌体-细菌相互作用
Viruses. 2021 Feb 19;13(2):318. doi: 10.3390/v13020318.
6
Combined bacteriophages and antibiotics as an efficient therapy against VRE Enterococcus faecalis in a mouse model.在小鼠模型中,联合使用噬菌体和抗生素作为治疗耐万古霉素粪肠球菌的有效疗法。
Res Microbiol. 2018 Nov;169(9):531-539. doi: 10.1016/j.resmic.2018.04.008. Epub 2018 May 16.
7
Phage therapy: A renewed approach against oral diseases caused by Enterococcus faecalis infections.噬菌体疗法:一种针对粪肠球菌感染引起的口腔疾病的新方法。
Microb Pathog. 2024 Apr;189:106574. doi: 10.1016/j.micpath.2024.106574. Epub 2024 Feb 13.
8
Fully Characterized Effective Bacteriophages Specific against Antibiotic-Resistant , the Causative Agent of Dental Abscess.针对导致牙龈脓肿的抗生素耐药菌,全面鉴定有效的噬菌体。
Medicina (Kaunas). 2024 Mar 19;60(3):501. doi: 10.3390/medicina60030501.
9
Genetically distant bacteriophages select for unique genomic changes in Enterococcus faecalis.遗传上不同的噬菌体在粪肠球菌中选择独特的基因组变化。
Microbiologyopen. 2022 Apr;11(2):e1273. doi: 10.1002/mbo3.1273.
10
Lytic bacteriophages against multidrug-resistant Staphylococcus aureus, Enterococcus faecalis and Escherichia coli isolates from orthopaedic implant-associated infections.针对骨科植入物相关感染的耐多药金黄色葡萄球菌、粪肠球菌和大肠杆菌分离株的裂解噬菌体。
Int J Antimicrob Agents. 2019 Sep;54(3):329-337. doi: 10.1016/j.ijantimicag.2019.06.007. Epub 2019 Jun 21.

引用本文的文献

1
Characterization and application of a novel phage CC_R7 as a biocontrol agent in chicken meat.新型噬菌体CC_R7作为鸡肉生物防治剂的特性及应用
Curr Res Food Sci. 2025 Aug 20;11:101182. doi: 10.1016/j.crfs.2025.101182. eCollection 2025.
2
Antibacterial and Antibiofilm Efficacy of Endolysin LysEf-9 and Crude Bacteriocin Against Multidrug and Phage-Resistant Enterococci.内溶素LysEf-9和粗制细菌素对多重耐药及噬菌体抗性肠球菌的抗菌和抗生物膜功效
Probiotics Antimicrob Proteins. 2025 Jun 7. doi: 10.1007/s12602-025-10616-0.
3
A novel thermostable lytic phage vB_EF_Enf3_CCASU-2024-3 against clinical Enterococcus faecium and Enterococcus faecalis.

本文引用的文献

1
Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria.噬菌体疗法:一种对抗抗生素耐药菌的新方法。
Cell Host Microbe. 2019 Feb 13;25(2):219-232. doi: 10.1016/j.chom.2019.01.014.
2
(Ph)ighting Phages: How Bacteria Resist Their Parasites.(Ph)ighting Phages: 细菌如何抵抗其寄生虫。
Cell Host Microbe. 2019 Feb 13;25(2):184-194. doi: 10.1016/j.chom.2019.01.009.
3
Combination Antimicrobial Therapy for Enterococcus faecalis Infective Endocarditis.粪肠球菌感染性心内膜炎的联合抗菌治疗
一种新型的针对临床粪肠球菌和屎肠球菌的耐热性裂解噬菌体vB_EF_Enf3_CCASU-2024-3。
AMB Express. 2025 Apr 26;15(1):65. doi: 10.1186/s13568-025-01871-z.
4
Prophylactic phage administration provides a time window for delayed treatment of vancomycin-resistant in a murine bacteremia model.在小鼠菌血症模型中,预防性噬菌体给药为耐万古霉素菌的延迟治疗提供了一个时间窗口。
Front Microbiol. 2025 Jan 24;15:1504696. doi: 10.3389/fmicb.2024.1504696. eCollection 2024.
5
From Isolation to Application: Utilising Phage-Antibiotic Synergy in Murine Bacteremia Model to Combat Multidrug-Resistant Enterococcus faecalis.从分离到应用:在小鼠菌血症模型中利用噬菌体 - 抗生素协同作用对抗耐多药粪肠球菌
Microb Biotechnol. 2025 Jan;18(1):e70075. doi: 10.1111/1751-7915.70075.
6
Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their Biofilms.含有2,3-双(苯基氨基)喹喔啉的化合物对耐甲氧西林金黄色葡萄球菌、粪肠球菌及其生物膜具有活性。
Microbiologyopen. 2024 Dec;13(6):e011. doi: 10.1002/mbo3.70011.
7
A Comprehensive Review on Phage Therapy and Phage-Based Drug Development.噬菌体疗法与基于噬菌体的药物开发综述
Antibiotics (Basel). 2024 Sep 11;13(9):870. doi: 10.3390/antibiotics13090870.
8
Caffeic acid phenethyl ester attenuates infection in vivo: antioxidants and NF-κB have a protective role against stomach damage.咖啡酸苯乙酯体内减轻 感染:抗氧化剂和 NF-κB 对胃损伤有保护作用。
J Med Life. 2024 Jun;17(6):574-581. doi: 10.25122/jml-2023-0544.
9
A diverse set of Enterococcus-infecting phage provides insight into phage host-range determinants.多种不同的肠球菌噬菌体为噬菌体宿主范围决定因素提供了深入了解。
Virus Res. 2024 Sep;347:199426. doi: 10.1016/j.virusres.2024.199426. Epub 2024 Jul 4.
10
Genomic Characterization and Phylogenetic Analysis of Linezolid-Resistant Enterococcus from the Nostrils of Healthy Hosts Identifies Zoonotic Transmission.从健康宿主鼻腔中分离出的耐利奈唑烷肠球菌的基因组特征和系统发育分析表明存在人畜共患病传播。
Curr Microbiol. 2024 Jun 14;81(8):225. doi: 10.1007/s00284-024-03737-2.
Clin Infect Dis. 2019 Aug 16;69(5):900. doi: 10.1093/cid/ciz054.
4
The Preclinical and Clinical Progress of Bacteriophages and Their Lytic Enzymes: The Parts are Easier than the Whole.噬菌体及其裂解酶的临床前和临床进展:整体比部分更难。
Viruses. 2019 Jan 24;11(2):96. doi: 10.3390/v11020096.
5
Countermeasures Defeat a Virulent Bacteriophage.抗击烈性噬菌体的对策。
Viruses. 2019 Jan 10;11(1):48. doi: 10.3390/v11010048.
6
Clinical Indications and Compassionate Use of Phage Therapy: Personal Experience and Literature Review with a Focus on Osteoarticular Infections.临床适应症与噬菌体疗法的临床应用:个人经验与文献综述,重点关注骨关节炎感染。
Viruses. 2018 Dec 28;11(1):18. doi: 10.3390/v11010018.
7
A Wake-Up Call: We Need Phage Therapy Now.敲响警钟:我们现在就需要噬菌体疗法。
Viruses. 2018 Dec 5;10(12):688. doi: 10.3390/v10120688.
8
Characterization and genome analysis of novel phage vB_EfaP_IME195 infecting Enterococcus faecalis.新型噬菌体vB_EfaP_IME195感染粪肠球菌的特性及基因组分析
Virus Genes. 2018 Dec;54(6):804-811. doi: 10.1007/s11262-018-1608-6. Epub 2018 Nov 1.
9
Potential Application of Bacteriophages in Enrichment Culture for Improved Prenatal Screening.噬菌体在富集培养中提高产前筛查的潜在应用。
Viruses. 2018 Oct 10;10(10):552. doi: 10.3390/v10100552.
10
The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.利用家蚕感染模型靶向革兰氏阴性菌的噬菌体的治疗潜力。
BMC Microbiol. 2018 Aug 31;18(1):97. doi: 10.1186/s12866-018-1234-4.